April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
An Efficient Near-Infrared Photothermal Therapy Agent by Using Ag @ Oxides Nanoprisms in for Cancer Therapy
Author Affiliations & Notes
  • Chuang Nie
    Ophthalmology, The 301th Hospital of PLA, Beijing, China
    Ophthalmology, The 306th Hospital of PLA, Beijing, China
  • Peng Du
    Changchun Institute of Optics, Changchun, China
  • Hongwei Zhao
    Ophthalmology, The 306th Hospital of PLA, Beijing, China
  • Huawen Ma
    Ophthalmology, The 306th Hospital of PLA, Beijing, China
  • Lianna Hu
    Ophthalmology, The 306th Hospital of PLA, Beijing, China
  • Alex Jones
    Moran eye center, Salt Lake City, UT
  • Maonian Zhang
    Ophthalmology, The 301th Hospital of PLA, Beijing, China
  • Balamurali Ambati
    Moran eye center, Salt Lake City, UT
  • Zaicheng Sun
    Changchun Institute of Optics, Changchun, China
  • Ling Luo
    Ophthalmology, The 306th Hospital of PLA, Beijing, China
  • Footnotes
    Commercial Relationships Chuang Nie, None; Peng Du, None; Hongwei Zhao, None; Huawen Ma, None; Lianna Hu, None; Alex Jones, None; Maonian Zhang, None; Balamurali Ambati, None; Zaicheng Sun, None; Ling Luo, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4631. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chuang Nie, Peng Du, Hongwei Zhao, Huawen Ma, Lianna Hu, Alex Jones, Maonian Zhang, Balamurali Ambati, Zaicheng Sun, Ling Luo; An Efficient Near-Infrared Photothermal Therapy Agent by Using Ag @ Oxides Nanoprisms in for Cancer Therapy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4631.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Photothermal therapy (PTT) have been used in cancer therapy in recent years. We created a new PTT agent --Silver-oxides core-shell nanoprisms (Ag@oxides NPs) that possess stronger near-infrared (NIR) absorption and higher phototherma conversion efficiency. The purpose of this study was to demonstrate Ag @oxides nanoprisms can be used as an effective PTT agent in vivo and vitro.

Methods: Ag NPs were synthesized using a seed-mediated procedure. Ag@oxides NPs were prepared via a simple sol-gel route. The thickness of the oxides shell can be precisely tuned from 1 to 15 nm through changing the reaction time and amount of oxides sol-gel precursor. Cytotoxicity of Ag NP was tested in B16F10 cells using MTT assay, and C57BL/6J mice with subcutaneous melanoma tumor model. For measuring the photothermal conversion performance of the Ag@oxides core-shell NPs, 1mL aqueous dispersion of Ag@oxides NPs with different concentrations were introduced in a quartz cuvette and irradiated with an 808 nm NIR laser at a power density of 2 W*cm-2. Ag@oxides NPs were added into the co-cultured medium with cancer cells or injected into the tumor body. The cells/tumor were exposed to an 808 nm laser at 2 W*cm-2 for 1 min, immediately. The photothermal effectiveness of Ag NP was evaluated by observing cellular survival using MTT assay and measuring the size of the tumor.

Results: We developed a facile method to synthesize Ag@oxides core-shell NPs with a tunable shell thickness through the simple sol-gel route. Ag@oxides exhibits a good biocompatiblity and stability for in vivo and vitro due to the existence of oxide shell layer. The localized surface plasmon resonance (LSPR) absorption band of Ag@oxides appeared at approximately 808 nm known as the Near-Infrared Window. When the light at 808 nm illuminated the Ag@oxides NPs, the temperature of media surrounding Ag@oxides NPs rapidly rose up, resulting in significant B16F10 cells death in Ag NPs-treated cells in vitro (p<0.01, t = 19.887). NIR laser irradiation decreased the tumor volume (tumor volume=(tumor length) ×(tumor width)2/2) gradually and completely ablated by 14 days treatment. The cells showed well tolerated to Ag@oxides NPs and the mice remained healthy over one-month period.

Conclusions: Ag@oxides NPs were demonstrated to be an efficient photothermal therapy agent for solid cancers by local delivery.

Keywords: 744 tumors • 608 nanomedicine • 589 melanoma  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×